Motto International Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with recall — FDA D-0656-2020
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Overview of recall records associated with Motto International Corp, including dates, categories and classifications where available.
Classification mix: Class I: 2.
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
This page summarizes recall records in which the official source identifies Motto International Corp as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.